These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10446853)

  • 1. ACR 20: clinical or statistical significance?
    Pincus T; Stein CM
    Arthritis Rheum; 1999 Aug; 42(8):1572-6. PubMed ID: 10446853
    [No Abstract]   [Full Text] [Related]  

  • 2. [ACR preliminary definition, of improvement in rheumatoid arthritis].
    Homma M
    Ryumachi; 1996 Dec; 36(6):891-900. PubMed ID: 9122830
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
    Schnabel A; Gross WL
    Dtsch Med Wochenschr; 2003 Jan; 128(4):147-9. PubMed ID: 12589584
    [No Abstract]   [Full Text] [Related]  

  • 4. Improvement criteria--clinical and statistical significance: comment on the article by Pincus and Stein.
    van Gestel AM; van Riel PL
    Arthritis Rheum; 2000 Jul; 43(7):1658-60. PubMed ID: 10902775
    [No Abstract]   [Full Text] [Related]  

  • 5. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration.
    Anderson JJ; Wells G; Verhoeven AC; Felson DT
    Arthritis Rheum; 2000 Jan; 43(1):22-9. PubMed ID: 10643696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-modifying drugs in rheumatoid arthritis.
    Rahman A; Ahmed S; Underwood M
    Practitioner; 2001 Dec; 245(1629):1018-25. PubMed ID: 11771221
    [No Abstract]   [Full Text] [Related]  

  • 7. Leflunomide for rheumatoid arthritis.
    Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Financial interests characterize published reports on coxiber. Whom can we rely on?].
    Håkansson J
    Lakartidningen; 2002 Oct; 99(40):3930-1. PubMed ID: 12422746
    [No Abstract]   [Full Text] [Related]  

  • 9. Shouldn't standard rheumatology clinical care be evidence-based rather than eminence-based, eloquence-based, or elegance-based?
    Pincus T; Tugwell P
    J Rheumatol; 2007 Jan; 34(1):1-4. PubMed ID: 17216670
    [No Abstract]   [Full Text] [Related]  

  • 10. The systematic study of drug therapy in rheumatoid arthritis.
    Johnson K
    J Rheumatol Suppl; 1990 Nov; 25():34-8. PubMed ID: 2273520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eligibility of rheumatoid arthritis patients seen in clinical practice for rheumatoid arthritis clinical trials: comment on the article by Sokka and Pincus.
    Yazici Y; Erkan D
    Arthritis Rheum; 2003 Dec; 48(12):3611; author reply 3613-5. PubMed ID: 14674017
    [No Abstract]   [Full Text] [Related]  

  • 12. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or american college of rheumatology criteria for remission.
    Sokka T; Pincus T
    J Rheumatol; 2003 Jun; 30(6):1138-46. PubMed ID: 12784382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of drug use in rheumatoid arthritis.
    Rau R; Wassenberg S; Zeidler H
    J Rheumatol; 2001 Jun; 28(6):1463; author reply 1464-5. PubMed ID: 11409145
    [No Abstract]   [Full Text] [Related]  

  • 14. Patterns of drug use in rheumatoid arthritis.
    Roger L
    J Rheumatol; 2001 Jun; 28(6):1463-4; author reply 1464-5. PubMed ID: 11409144
    [No Abstract]   [Full Text] [Related]  

  • 15. Drugs for rheumatoid arthritis.
    Treat Guidel Med Lett; 2009 May; 7(81):37-46; quiz 47-8. PubMed ID: 19390497
    [No Abstract]   [Full Text] [Related]  

  • 16. Drugs for rheumatoid arthritis.
    Treat Guidel Med Lett; 2005 Dec; 3(40):83-90. PubMed ID: 16299450
    [No Abstract]   [Full Text] [Related]  

  • 17. Towards an epidemiology of rheumatoid arthritis outcome with respect to treatment: randomized controlled trials overestimate treatment response and effectiveness.
    Wolfe F; Michaud K
    Rheumatology (Oxford); 2005 Dec; 44 Suppl 4():iv18-iv22. PubMed ID: 16306476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [So that the patients.would be able to move for a long time after first diagnosis of rheumatism. Approach as an emergency!].
    Fath R
    MMW Fortschr Med; 2004 Sep; 146(37):4-5. PubMed ID: 15887690
    [No Abstract]   [Full Text] [Related]  

  • 19. Advances in the treatment of early rheumatoid arthritis.
    Vital EM; Emery P
    Am Fam Physician; 2005 Sep; 72(6):1002, 1004. PubMed ID: 16190499
    [No Abstract]   [Full Text] [Related]  

  • 20. Add-on or step-up trials for new drug development in rheumatoid arthritis: a new standard?
    Boers M
    Arthritis Rheum; 2003 Jun; 48(6):1481-3. PubMed ID: 12794813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.